Pipeline

At GSK, our pipeline is focused on unlocking the science of the immune system, human genetics, and advanced technologies to develop vaccines and specialty medicines.

Our products in development progress through three stages: phase I, phase II, and phase III/registrational. Each of these phases allows us to assess the safety and efficacy of our investigational products to eventually provide data to support applications for regulatory approval.

DISEASE STATES

ANEMIA OF CHRONIC KIDNEY DISEASE (CKD)
Phase 3

ASCEND (Anemia studies in CKD)

ASCEND-P: Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric

Go to ResourceOpen link icon

0 results - Use filter to search Pipeline

Disclaimer

This document contains information for healthcare providers and is intended solely for educational purposes. This display includes ongoing clinical trials for both approved and investigational compounds.

Some agents are approved in select indications. Inclusion in this display does not imply regulatory approval for these compounds or all indications. Information about all trials can be found at www.clinicaltrials.gov.